Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure. Εκτύπωση
Συντάχθηκε απο τον/την gkatsaros   
Δευτέρα, 08 Φεβρουάριος 2010 12:22

Levosimendan use reduces matrix metalloproteinase-2 in patients with decompensated heart failure.

Tziakas DN, Chalikias GK, Hatzinikolaou HI, Stakos DA, Papanas N, Tentes IK, Kortsaris AX, Maltezos E, Hatseras DI, Kaski JC.

Cardiovasc Drugs Ther. 2005 Dec;19(6):399-402.PMID: 16435069 [PubMed - indexed for MEDLINE]Related articles